The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Microsphere Drug Market Research Report 2024

Global Microsphere Drug Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742853

No of Pages : 85

Ask Your Query

Synopsis
Microsphere drug refers to a drug delivery system that uses micron-scale spherical particles as drug carriers, and wraps and encapsulates drug substances inside or on the surface of drug microspheres. By controlling the release rate and directional delivery of drug microspheres, this drug delivery system can achieve sustained drug release, reduce drug dose, improve drug stability, and regulate drug distribution and efficacy in vivo.

Global Microsphere Drug market is projected to reach US$ 11720 million in 2029, increasing from US$ 8800 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microsphere Drug market research.

Key companies engaged in the Microsphere Drug industry include Johnson & Johnson, Takeda, Novartis, Ipsen Biopharmaceuticals, Inc, Ferring Pharmaceuticals, AstraZeneca, Pfizer, AbbVie and Beijing Biote Pharmaceutical Co.,Ltd, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Microsphere Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Microsphere Drug market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microsphere Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Johnson & Johnson
  • Takeda
  • Novartis
  • Ipsen Biopharmaceuticals, Inc
  • Ferring Pharmaceuticals
  • AstraZeneca
  • Pfizer
  • AbbVie
  • Beijing Biote Pharmaceutical Co.,Ltd
  • Livzon Pharmaceutical Group
  • Luye Pharma
  • Grand Pharmaceutical Group Limited

Segment by Type

  • Leuprolide Microspheres
  • Risperidone Microspheres
  • Octreotide Microspheres
  • Triptorelin Microspheres
  • other

Segment by Application

  • Cancer
  • Mental Illness
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Microsphere Drug report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Microsphere Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Leuprolide Microspheres
Table 3. Key Players of Risperidone Microspheres
Table 4. Key Players of Octreotide Microspheres
Table 5. Key Players of Triptorelin Microspheres
Table 6. Key Players of other
Table 7. Global Microsphere Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Microsphere Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Microsphere Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Microsphere Drug Market Share by Region (2018-2023)
Table 11. Global Microsphere Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Microsphere Drug Market Share by Region (2024-2029)
Table 13. Microsphere Drug Market Trends
Table 14. Microsphere Drug Market Drivers
Table 15. Microsphere Drug Market Challenges
Table 16. Microsphere Drug Market Restraints
Table 17. Global Microsphere Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Microsphere Drug Market Share by Players (2018-2023)
Table 19. Global Top Microsphere Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microsphere Drug as of 2022)
Table 20. Ranking of Global Top Microsphere Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Microsphere Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Microsphere Drug Product Solution and Service
Table 24. Date of Enter into Microsphere Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microsphere Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Microsphere Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Microsphere Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Microsphere Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Microsphere Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Microsphere Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Microsphere Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Microsphere Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Microsphere Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Microsphere Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Microsphere Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Microsphere Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Microsphere Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Microsphere Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Microsphere Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Microsphere Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Microsphere Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Microsphere Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Microsphere Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Microsphere Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Microsphere Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Microsphere Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Microsphere Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Johnson & Johnson Company Detail
Table 50. Johnson & Johnson Business Overview
Table 51. Johnson & Johnson Microsphere Drug Product
Table 52. Johnson & Johnson Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 53. Johnson & Johnson Recent Development
Table 54. Takeda Company Detail
Table 55. Takeda Business Overview
Table 56. Takeda Microsphere Drug Product
Table 57. Takeda Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 58. Takeda Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Microsphere Drug Product
Table 62. Novartis Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Ipsen Biopharmaceuticals, Inc Company Detail
Table 65. Ipsen Biopharmaceuticals, Inc Business Overview
Table 66. Ipsen Biopharmaceuticals, Inc Microsphere Drug Product
Table 67. Ipsen Biopharmaceuticals, Inc Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 68. Ipsen Biopharmaceuticals, Inc Recent Development
Table 69. Ferring Pharmaceuticals Company Detail
Table 70. Ferring Pharmaceuticals Business Overview
Table 71. Ferring Pharmaceuticals Microsphere Drug Product
Table 72. Ferring Pharmaceuticals Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 73. Ferring Pharmaceuticals Recent Development
Table 74. AstraZeneca Company Detail
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Microsphere Drug Product
Table 77. AstraZeneca Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 78. AstraZeneca Recent Development
Table 79. Pfizer Company Detail
Table 80. Pfizer Business Overview
Table 81. Pfizer Microsphere Drug Product
Table 82. Pfizer Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. AbbVie Company Detail
Table 85. AbbVie Business Overview
Table 86. AbbVie Microsphere Drug Product
Table 87. AbbVie Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 88. AbbVie Recent Development
Table 89. Beijing Biote Pharmaceutical Co.,Ltd Company Detail
Table 90. Beijing Biote Pharmaceutical Co.,Ltd Business Overview
Table 91. Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Product
Table 92. Beijing Biote Pharmaceutical Co.,Ltd Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 93. Beijing Biote Pharmaceutical Co.,Ltd Recent Development
Table 94. Livzon Pharmaceutical Group Company Detail
Table 95. Livzon Pharmaceutical Group Business Overview
Table 96. Livzon Pharmaceutical Group Microsphere Drug Product
Table 97. Livzon Pharmaceutical Group Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 98. Livzon Pharmaceutical Group Recent Development
Table 99. Luye Pharma Company Detail
Table 100. Luye Pharma Business Overview
Table 101. Luye Pharma Microsphere Drug Product
Table 102. Luye Pharma Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 103. Luye Pharma Recent Development
Table 104. Grand Pharmaceutical Group Limited Company Detail
Table 105. Grand Pharmaceutical Group Limited Business Overview
Table 106. Grand Pharmaceutical Group Limited Microsphere Drug Product
Table 107. Grand Pharmaceutical Group Limited Revenue in Microsphere Drug Business (2018-2023) & (US$ Million)
Table 108. Grand Pharmaceutical Group Limited Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microsphere Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Microsphere Drug Market Share by Type: 2022 VS 2029
Figure 3. Leuprolide Microspheres Features
Figure 4. Risperidone Microspheres Features
Figure 5. Octreotide Microspheres Features
Figure 6. Triptorelin Microspheres Features
Figure 7. other Features
Figure 8. Global Microsphere Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Microsphere Drug Market Share by Application: 2022 VS 2029
Figure 10. Cancer Case Studies
Figure 11. Mental Illness Case Studies
Figure 12. Other Case Studies
Figure 13. Microsphere Drug Report Years Considered
Figure 14. Global Microsphere Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Microsphere Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Microsphere Drug Market Share by Region: 2022 VS 2029
Figure 17. Global Microsphere Drug Market Share by Players in 2022
Figure 18. Global Top Microsphere Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microsphere Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Microsphere Drug Revenue in 2022
Figure 20. North America Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Microsphere Drug Market Share by Country (2018-2029)
Figure 22. United States Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Microsphere Drug Market Share by Country (2018-2029)
Figure 26. Germany Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Microsphere Drug Market Share by Region (2018-2029)
Figure 34. China Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Microsphere Drug Market Share by Country (2018-2029)
Figure 42. Mexico Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Microsphere Drug Market Share by Country (2018-2029)
Figure 46. Turkey Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Microsphere Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 49. Takeda Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 51. Ipsen Biopharmaceuticals, Inc Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 52. Ferring Pharmaceuticals Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 54. Pfizer Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 56. Beijing Biote Pharmaceutical Co.,Ltd Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 57. Livzon Pharmaceutical Group Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 58. Luye Pharma Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 59. Grand Pharmaceutical Group Limited Revenue Growth Rate in Microsphere Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock